Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin

Cell Biochemistry and Biophysics

Volumn 38, Issue 1, 2003, Pages 1-21

  Hamel, Ernest ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antimitotic drugs; Combretastatin A 4; Docetaxel; GDP; Glutamate; GTP; Microtubules; Paclitaxel; Tubulin polymerization

Indexed keywords

ANTINEOPLASTIC AGENT; COMBRETASTATIN A 4; COMBRETASTATIN A-4; GLUTAMIC ACID DERIVATIVE; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; POLYMER; STILBENE DERIVATIVE; TUBULIN;

BINDING SITE; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; EVALUATION; ISOLATION AND PURIFICATION; MICROTUBULE; MITOSIS; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SYNTHESIS;

ANTINEOPLASTIC AGENTS; BINDING SITES; GLUTAMATES; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; MICROTUBULES; MITOSIS; POLYMERS; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; STILBENES; TUBULIN;

EID: 0142036683     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1385/CBB:38:1:1     Document Type: Article

References (76)

1. Yeh, H. J. C., Chrzanowska, M., and Brossi, A. (1988) The importance of the phenyl-tropolone "aS" configuration in colchicine's binding to rubulin. FEBS Lett. 229, 82-86.
2. Rowinsky, E. K. and Donehower, R. C. (1995) Paclitaxel (Taxol). N. Engl. J. Med. 332, 1004-1014.
3. Cortes, J. E. and Pazdur, R. (1995) Docetaxel. J. Clin. Oncol. 13, 2643-2655.
4. McKellar, Q. A. and Scott, E. W. (1990) The benzimidazole anthelmintic agents - a review. J. Vet. Pharmacol. Ther. 13, 223-247.
5. Ben-Chetrit, E. and Levy, M. (1998) Colchicine: 1998 update. Semin. Arthritis Rheum. 28, 48-59.
6. Schiff, P. B., Fant, J., and Horwitz, S. B. (1979) Promotion of microtubule assembly in vitro by taxol. Nature (London) 277, 665-667.
7. Bollag, D. M., McQueney, P. A., Zhu, J., et al. (1995) Epothilones, a new class of microtubule stabilizing agents with a taxol-like mechanism of action. Cancer Res. 55, 2325-2333.
8. ter Haar, E., Kowalski, R. J., Hamel, E., et al. (1996) Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. Biochemistry 35, 243-250.
9. Long, B. H., Carboni, J. M., Wasserman, A. J., et al. (1998) Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol®). Cancer Res. 58, 1111-1115.
10. Mooberry, S. L., Tien, G., Hernandez, A. H., Plubrukarn, A., and Davidson, B. S. (1999) Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents. Cancer Res. 59, 653-660.
11. Pryor, D. E., O'Brate, A., Bilcer, G., et al. (2002) The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity. Biochemistry 41, 9109-9115.
12. Bai, R., Lin, C. M., Nguyen, N. Y., Liu, T.-Y., and Hamel, E. (1989) Identification of the cysteine residue of β-tubulin alkylated by the antimitotic agent 2,4-dichlorobenzyl thiocyanate, facilitated by separation of the protein subunits of tubulin by hydrophobic column chromatography. Biochemistry 28, 5606-5612.
13. Shan, B., Medina, J. C., Santha, E., et al. (1999) Selective, covalent modification of β-tubulin residue Cys-239 by Tl38067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proc. Natl. Acad. Sci. USA 96, 5686-5691.
14. Legault, J., Gaulin, J.-F., Mounetou, E., et al. (2000) Microtubule disruption induced in vivo by alkylation of β-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents. Cancer Res. 60, 985-992.
15. Combeau, C., Provost, J., Lancelin, F., et al. (2000) RPR112378 and RPR115781: two representatives of a new family of microtubule assembly inhibitors. Mol. Pharmacol. 57, 553-563.
16. Wilson, L. (1970) Properties of colchicine binding protein from chick embryo brain. Interactions with vinca alkaloids and podophyllotoxin. Biochemistry 9, 4999-5007.
17. Schiff, P. B., Kende, A. S., and Horwitz, S. B. (1978) Steganacin: an inhibitor of HeLa cell growth and microtubule assembly in vitro. Biochem. Biophys. Res. Commun. 85, 737-746.
18. Lin, C. M., Singh, S. B., Chu, P. S., et al. (1988) Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study. Mol. Pharmacol. 34, 200-208.
19. D'Amato, R. J., Lin, C. M., Flynn, E., Folkman, J., and Hamel, E. (1994) 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc. Natl. Acad. Sci. USA 91, 3964-3968.
20. Blokhin, A. V., Yoo, H.-D., Geralds, R. S., Nagle, D. G., Gerwick, W. H., and Hamel, E. (1995) Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogs. Mol. Pharmacol. 48, 523-531.
21. Hoebeke, J., Van Nijen, G., and De Brabander, M. (1976) Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin. Biochem. Biophys. Res. Commun. 69, 319-324.
22. Friedman, P. A. and Platzer, E. G. (1978) Interaction of anthelmintic benzimidazoles and benzimidazole derivatives with bovine brain tubulin. Biochim. Biophys. Acta 544, 605-614.
23. Beutler, J. A., Hamel, E., Vlietinck, A. J., et al. (1998) Structure-activity requirements for flavone cytotoxicity and binding to tubulin. J. Med. Chem. 41, 2333-2338.
24. Hour, M.-J., Huang, L.-J., Kuo, S.-C., et al. (2000) 6-Alkylamino and 2,3-dihydro-3′-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J. Med. Chem. 43, 4479-4487.
25. Paull, K. D., Lin, C. M., Malspeis, L., and Hamel, E. (1992) Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data. Cancer Res. 52, 3892-3900.
26. Bai, R., Covell, D. G., Pei, X.-F., et al. (2000) Mapping the binding site of colchicinoids on β-tubulin: 2-chloroacetyl-2-demethylthiocolchicine covalently reacts predominantly with cysteine 239 and secondarily with cysteine 354. J. Biol. Chem. 275, 40,443-40,452.
27. Sternlicht, H. and Ringel, I. (1979) Colchicine inhibition of microtubule assembly via copolymer formation. J. Biol. Chem. 254, 10,540-10,548.
28. Sternlicht, H., Ringel, I., and Szasz, J. (1980) The co-polymerization of tubulin and tubulin-colchicine complex in the absence and presence of associated proteins. J. Biol. Chem. 255, 9138-9148.
29. Bai, R., Pettit, G. R., and Hamel, E. (1990) Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites. J. Biol. Chem. 265, 17,141-17,149.
30. Bai, R., Paull, K. D., Herald, C. L., Malspeis, L., Pettit, G. R., and Hamel, E. (1991) Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin: discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. J. Biol. Chem. 266, 15,882-15,889.
31. Bai, R., Cichacz, Z. A., Herald, C. L., Pettit, G. R., and Hamel, E. (1993) Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin. Mol. Pharmacol. 44, 757-766.
32. Bai, R., Taylor, G. F., Cichacz, Z. A., et al. (1995) The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain. Biochemistry 34, 9714-9719.
33. Hamel, E. and Covell, D. G. (2002) Antimitotic peptides and depsipeptides. Curr. Med. Chem. - Anti-Cancer Agents 2, 19-53.
34. Wilson, L., Jordan, M. A., Morse, A., and Margolis, R. L. (1982) Interaction of vinblastine with steady-state microtubules in vitro. J. Mol. Biol. 159, 125-149.
35. Jordan, M. A., Margolis, R. L., Himes, R. H., and Wilson, L. (1986) Identification of a distinct class of vinblastine binding sites on microtubules. J. Mol. Biol. 187, 61-73.
36. Jordan, M. A. (2002) Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr. Med. Chem. - Anti-Cancer Agents 2, 1-17.
37. Duanmu, C., Shahrik, L., Ho, H. H., and Hamel, E. (1989) Tubulin-dependent hydrolysis of GTP as a screening test to identify new antimitotic agents: application to carbamates of aromatic amines. Cancer Res. 49, 1344-1348.
38. Gaskin, F., Cantor, C. R., and Shelanski, M. L. (1974) Turbidimetric studies of the in vitro assembly and disassembly of porcine neurotubules. J. Mol. Biol. 89, 737-758.
39. Weisenberg, R. C. (1972) Microtubule formation in vitro in solutions containing low calcium concentrations. Science 177, 1104-1105.
40. Shelanski, M. L., Gaskin, F., and Cantor, C. R. (1973) Microtubule assembly in the absence of added nucleotides. Proc. Natl. Acad. Sci. USA 70, 765-768.
41. Cleveland, D. W., Hwo, S.-Y., and Kirschner, M. W. (1977) Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J. Mol. Biol. 116, 227-247.
42. Murphy, D. B., Johnson, K. A., and Borisy, G. G. (1977) Role of tubulin-associated proteins in microtubule nucleation and elongation. J. Mol. Biol. 117, 33-52.
43. Olmsted, J. B. and Borisy, G. G. (1975) Ionic and nucleotide requirements for microtubule polymerization in vitro. Biochemistry 14, 2996-3004.
44. Pierson, G. B., Burton, P. R., and Himes, R. H. (1978) Alterations in number of protofilaments in microtubules assembled in vitro. J. Cell Biol. 76, 223-228.
45. Böhm, K. J., Vater, W., Fenske, H., and Unger, E. (1984) Effect of microtubule-associated proteins on the protofilament number of microtubules assembled in vitro. Biochim. Biophys. Acta 800, 119-126.
46. Chrétien, D., Verde, F., Karsenti, E., and Wade, R. H. (1992) Lattice defects in microtubules: protofilament numbers vary within individual microtubules. J. Cell Biol. 117, 1031-1040.
47. Waxman, P. G., del Campo, A. A., Lowe, M. C., and Hamel, E. (1981) Induction of polymerization of purified tubulin by sulfonate buffers: marked differences between 4-morpholineethanesulfonate (Mes) and 1,4- piperazineethanesulfonate (Pipes). Eur. J. Biochem. 120, 129-136.
48. Frigon, R. P. and Timasheff, S. N. (1975) Magnesium-induced self-association of calf brain tubulin. I. Stoichiometry. Biochemistry 14, 4559-4566.
49. Frigon, R. P. and Timasheff, S. N. (1975) Magnesium-induced self-association of calf brain tubulin. II. Thermodynamics. Biochemistry 14, 4567-4573.
50. Himes, R. H., Burton, P. R., and Gaito, J. M. (1977) Dimethyl sulfoxide-induced self-assembly of tubulin lacking associated proteins. J. Biol. Chem. 252, 6222-6228.
51. Hamel, E. and Lin, C. M. (1981) Glutamate-induced polymerization of tubulin: characteristics of the reaction and application to the large-scale purification of tubulin. Arch. Biochem. Biophys. 209, 29-40.
52. Hamel, E. and Lin, C. M. (1981) Stabilization of the colchicine-binding activity of tubulin by organic acids. Biochim. Biophys. Acta 675, 226-231.
53. Himes, R. H. (1991) Interactions of the Catharanthus (Vinca) alkaloids with tubulin and microtubules. Pharmacol. Ther. 51, 257-267.
54. Bai, R., Taylor, G. F., Schmidt, J. M., et al. (1995) Interaction of dolastatin 10 with tubulin: induction of aggregation and binding and dissociation reactions. Mol. Pharmacol. 47, 965-976.
55. Hamel, E., Blokhin, A. V., Nagle, D. G., Yoo, H.-D., and Gerwick, W. H. (1995) Limitations in the use of tubulin polymerization assays as a screen for the identification of new antimitotic agents: the potent marine natural product curacin A as an example. Drug Dev. Res. 34, 110-120.
56. Hastie, S. B. (1991) Interactions of colchicine with tubulin. Pharmacol. Ther. 51, 377-401.
57. Grover, S., Boyé, O., Getahun, Z., Brossi, A., and Hamel, E. (1992) Chloroacetates of 2- and 3-demethylthiocolchicine: specific covalent interaction with tubulin with preferential labeling of the β-subunit. Biochem. Biophys. Res. Commun. 187, 1350-1358.
58. Abraham, I., Dion, R. L., Duanmu, C., Gottesman, M. M., and Hamel, E. (1986) 2,4-Dichlorobenzyl thiocyanate, an antimitotic agent that alters microtubule morphology. Proc. Natl. Acad. Sci. USA 83, 6839-6843.
59. Bai, R., Duanmu, C., and Hamel, E. (1989) Mechanism of action of the antimitotic drug 2,4-dichlorobenzyl thiocyanate: alkylation of sulfhydryl group(s) of β-tubulin. Biochim. Biophys. Acta 994, 12-20.
60. Pinney, K. G., Bounds, A. D., Dingeman, K. M., et al. (1999) A new anti-tubulin agent containing the benzo[b]thiophene ring system. Bioorg. Med. Chem. Lett. 9, 1081-1086.
61. 2+ dependence of guanine nucleotide binding to tubulin. J. Biol. Chem. 262, 17,278-17,284.
62. Osei, A. A., Everett, G. W., and Himes, R. H. (1990) Evidence that the tightly bound magnesium in tubulin is associated with the N-site GTP. FEBS Lett. 276, 85-87.
63. Grover, S. and Hamel, E. (1994) The magnesium-GTP interaction in microtubule assembly. Eur. J. Biochem. 222, 163-172.
64. Lin, C. M., Ho, H. H., Pettit, G. R., and Hamel, E. (1989) Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin. Biochemistry 28, 6984-6991.
65. Gaskin, F. and Kress, Y. (1977) Zinc ion-induced assembly of tubulin. J. Biol. Chem. 252, 6918-6924.
66. Buttlaire, D. H., Czuba, B. A., Stevens, T. H., Lee, Y. C., and Himes, R. H. (1980) Manganous ion binding to tubulin. J. Biol. Chem. 255, 2164-2168.
67. Haskins, K. M., Zombola, R. R., Boling, J. M., Lee, Y. C., and Himes, R. H. (1980) Tubulin assembly induced by cobalt and zinc. Biochem. Biophys. Res. Commun. 95, 1703-1709.
68. Eagle, G. R., Zombola, R. R., and Himes, R. H. (1983) Tubulin-zinc interactions: binding and polymerization studies. Biochemistry 22, 221-228.
69. Himes, R. H., Lee, Y. C., Eagle, G. R., Haskins, K. M., Babler, S. D., and Ellermeier, J. (1982) The relationship between cobalt binding to tubulin and stimulation of assembly. J. Biol. Chem. 257, 5839-5845.
70. Huang, A. B., Lin, C. M., and Hamel, E. (1985) Differential effects of magnesium on tubulin-nucleotide interactions. Biochim. Biophys. Acta 832, 22-32.
71. Hamel, E. and Lin, C. M. (1984) Separation of active tubulin and microtubule-associated proteins by ultracentrifugation and isolation of a component causing the formation of microtubule bundles. Biochemistry 23, 4173-4184.
72. Hamel, E., Lustbader, J., and Lin, C. M. (1984) Deoxyguanosine nucleotide analogues: potent stimulators of microtubule nucleation with reduced affinity for the exchangeable nucleotide site of tubulin. Biochemistry 23, 5314-5325.
73. Verdier-Pinard, P., Wang, Z., Mohanakrishnan, A. K., Cushman, M., and Hamel, E. (2000) A steroid derivative with paclitaxel-like effects on tubulin polymerization. Mol. Pharmacol. 57, 568-575.
74. Hamel, E., Sackett, D. L., Vourloumis, D., and Nicolaou, K. C. (1999) The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site. Biochemistry 38, 5490-5498.
75. Lataste, H., Senilh, V., Wright, M., Guénard, D., and Potier, P. (1984) Relationships between the structures of taxol and baccatine III derivatives and their in vitro action on the disassembly of mammalian brain and Physarum amoebal microtubules. Proc. Natl. Acad. Sci. USA 81, 4090-4094.
76. Lin, C. M., Jiang, Y. Q., Chaudhary, A. G., Rimoldi, J. M., Kingston, D. G. I., and Hamel, E. (1996) A convenient tubulin-based quantitative assay for paclitaxel (Taxol) derivatives more effective in inducing assembly than the parent compound. Cancer Chemother. Pharmacol. 38, 136-140.